CTOR

NASDAQ · Equity

Citius Oncology, Inc.

US Healthcare Drug Manufacturers - Specialty & Generic

Latest week
29 May 2026
Close
0.798000
Fair value
5.352193
Expectation
Negative 43.92%
Weekly Close Trend Line Fair Value Activity Lines

Chart Summary

Key Points

Week Ending
29 May 2026
Latest Close
0.80
12-Week Change
-1.77%
Trend Signal
Inactive
Expectation
Negative 43.92%
Signal Weeks
0 of 12
Vs Trend Line
Below
Vs Fair Value
Below
Relative Strength
-57.39
Market Dynamics
0.29

Over the latest 12 completed weeks ending 2026-05-29, CTOR fell 1.77%, moving from 0.81 to 0.80. The latest weekly close is below the Trend Line and below Fair Value. Trend Signal is inactive on the latest week and was active in 0 of the last 12 weeks. Relative Strength is -57.39 and has softened across the 12-week window. Market Dynamics is 0.29 on the latest week. Expectation is negative at 43.92%.